Showing results (161-170 of 282) with videos related to

Sort By:
Pageof 29
Elife|August 3, 2013
Dynamin phosphorylation controls optimization of endocytosis for brief action potential burstsMoritz Armbruster, Mirko Messa, Shawn M Ferguson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2015
Dynamin 2-dependent endocytosis sustains T-cell receptor signaling and drives metabolic reprogramming in T lymphocytesTim Willinger, Matthew Staron, Shawn M Ferguson, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
JIP4 deficiency causes a lysosomal storage disease arising from impaired cystine effluxLayla M Nassar, Xiaojian Shi, Agnes Roczniak-Ferguson, et al.
The International Journal of Neuropsychopharmacology|January 7, 2011
Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortexSusan L Erickson, Anjalika R Gandhi, Josephine K Asafu-Adjei, et al.
BMC Neuroscience|June 24, 2009
Subcellular localization of the antidepressant-sensitive norepinephrine transporterHeinrich J G Matthies, Qiao Han, Angela Shields, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dotsIan D Tomlinson, Michael R Warnerment, John N Mason, et al.
The Journal of Experimental Medicine|March 19, 2014
Dynamin 2-dependent endocytosis is required for sustained S1PR1 signalingTim Willinger, Shawn M Ferguson, João P Pereira, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2007
Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporterJohn N Mason, Darlene C Deecher, Rhonda L Richmond, et al.
Pageof 29